Efficacy of paliperidone palmitate 3-month formulation in preventing hospital admissions. 60 months of follow-up

INTRODUCTION: Paliperidone Palmitate 3-month formulation (PP3M) has shown a significantly longer time to relapse compared to placebo, with similar efficacy and safety to Paliperidone Palmitate 1-month (PP1M). However, studies of longer duration are required. OBJECTIVES: The main objective of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero Guillena, S.L., Plasencia Garcia De Diego, B.O., Gotor Sanchez-Luengo, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562963/
http://dx.doi.org/10.1192/j.eurpsy.2022.730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562963/
http://dx.doi.org/10.1192/j.eurpsy.2022.730

Ejemplares similares